Novo Nordisk A/S
Novel Acylated Insulin Analogues and Uses Thereof
Last updated:
Abstract:
The present invention relates to novel insulin analogues and derivatives thereof, such as acylated insulin analogues, and their pharmaceutical use, in particular in the treatment or prevention of medical conditions relating to diabetes, obesity and cardiovascular diseases.
Status:
Application
Type:
Utility
Filling date:
5 Nov 2020
Issue date:
1 Apr 2021